Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1991 Jun:93:91-5.
doi: 10.1289/ehp.919391.

Molecular determinants of metastatic transformation

Affiliations
Review

Molecular determinants of metastatic transformation

S E Egan et al. Environ Health Perspect. 1991 Jun.

Abstract

In recent years, experimental systems have developed to analyze genetic and epigenetic regulation of the metastatic phenotype. Numerous studies have uncovered a potent role for transforming oncogenes in metastatic conversion. In addition, it has been shown that oncoprotein products operate in a dose-dependent fashion. The continued expression of oncoproteins is required to induce and regulate metastatic dissemination of tumor cells and, consequently, many of the signal transduction pathways that are controlled by the oncogene products can regulate metastasis. Exogenous growth factors that act through these same pathways also alter metastatic potential. Some primary and immortalized cells can be transformed by oncogenes but remain completely benign and nonmetastatic. Malignant transformation can be achieved in these cells through the cooperative interaction of specific oncogenes or loss of active suppression regulated by recessive genetic determinants. Therefore, it is likely that tumor cells acquire the metastatic phenotype through the cooperative interaction of dominant and recessive genetic alterations. This model is consistent with the correlative data accumulating in studies of human tumor specimens where more malignant carcinomas often contain both activating mutations in oncogenes and either inactivating mutations or loss of tumor-suppressor genes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Oncogene. 1988 Mar;2(3):241-7 - PubMed
    1. Int J Cancer. 1989 Mar 15;43(3):443-8 - PubMed
    1. Mol Cell Biol. 1987 Feb;7(2):830-7 - PubMed
    1. Science. 1987 Jan 9;235(4785):177-82 - PubMed
    1. J Natl Cancer Inst. 1988 Jun 1;80(7):468-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources